[ad_1]
Do you want to advertise on this site?
A voluntary of the clinical trial in Brazil of AstraZeneca / Oxford For him vaccine anti COVID-19 is dead. This was reported by Reuters, taken up by the Bloomberg agency, citing the Brazilian health authority Anvisa and the federal university of Sao Paulo, which helps coordinate phase 3 of the trial in the South American country.
The evaluations carried out “did not raise any concerns about the continuation of the ongoing study” for vaccine test. This was stated by the multinational AstraZeneca, which is developing the anti-Covid vaccine in collaboration with the University of Oxford and the Irbm of Pomezia, in reference to the news – later denied – of the death of a volunteer involved in the experiment. The final tests of step 3 in this vaccine candidate.
“We cannot comment – says AstraZeneca – on individual cases involved in the ongoing experimentation of the Oxford vaccine, strictly adhering to the regulation of clinical trials, but we can confirm that all the required verification processes were followed“All major medical events – specifies the multinational – are carefully evaluated by the trial’s clinical investigators, an independent monitoring committee and regulatory authorities. These evaluations did not give rise to concerns regarding the continuation of the ongoing study.” .
- Read here the GdB on newsstands today
- Subscribe to “News in 5 minutes” to receive a selection of the main news every day
reproduction reserved © www.giornaledibrescia.it
[ad_2]